Therapeutic intervention with anti-TNF alleviates colonic and hepatic toxicity induced by perfluorooctanoic acid (PFOA)Mendeley Data by Wei Li, Yongjing Qian, Xiaojing Cai, Yu He, Xiannan Meng, Ling Zhang

Subjects: Get full text

Analysis of Publications on Psoriasis and Tuberculosis by Sevil Alkan, İrem Şahinoğlu, Mustafa Serhat Şahinoğlu

Subjects: Get full text

Fatal toxoplasmic encephalitis triggered by anti-TNF therapy by Rodrigo A. Montoro, Michael Moran, Katherine A. Overmyer, Andrew Periaccante, Joshua J. Coon, Swapnil Lanjewar, Laura J. Knoll, Rob Striker

Subjects: “…Anti-TNF-α therapy…”
Get full text

Efficacy of switching from originator adalimumab to biosimilar adalimumab-AACF in patients with axial spondyloarthritis: a 12-month observational study by Fanny Alcira Reyes Neira, Barbara Bayeh, Karina Rossi Bonfiglioli, Nadia Emi Aikawa, Ana Paula Luppino Assad, Renata Miossi, Fernando Henrique Carlos de Souza, Carlos Emilio Insfrán, Henrique Ayres Mayrink Giardini, Emily Figueiredo Vieira Neves Yuki, Eloisa Bonfa, Carla Gonçalves Schahin Saad, Ana Cristina de Medeiros-Ribeiro, Julio Cesar Bertacini de Moraes, Andrea Yukie Shimabuco

Subjects: “…anti-tnf biologics…”
Get full text

Infliximab Biosimilar Utilization in a Large Pediatric Learning Health System by Ross M. Maltz, Shehzad A. Saeed, Jeremy Adler

Subjects: Get full text

Superior persistence of ustekinumab compared to anti-TNF in vedolizumab-experienced inflammatory bowel diseases patients: a real-world cohort study by Horng-Yih Chiu, Chia-Jung Kuo, Ming-Wei Lai, Ren-Chin Wu, Chien-Ming Chen, Cheng-Tang Chiu, Yu-Bin Pan, Cheng-Hsun Chiu, Puo-Hsien Le

Subjects: Get full text

Acute Brucella melitensis M16 infection model in mice treated with tumor necrosis factor-alpha inhibitors by Murat Kutlu, Çağrı Ergin, Nilay Sen-Türk, Selda Sayin-Kutlu, Orcun Zorbozan, Serife Akalın, Barboros Sahin, Veli Cobankara, Neşe Demirkan

Subjects: Get full text

Correlation of anti-TNF-a biological therapy with periodontal conditions and osteonecrosis in autoimmune patients: A systematic review by Rana Majdi Abunemer, Rakan Saifuddin Shaheen, Renad Abudullah Alghamdi

Subjects: Get full text

El papel de los biosimilares en la enfermedad inflamatoria intestinal: una realidad en nuestro país by Juan Ricardo Márquez Velásquez, Fernando Gomollón García

Subjects: Get full text

The effects of disease activity on sleep disorders in ankylosing spondylitis patients by Ali Karataş, Tahsin Murat Turgay, Orhan Küçükşahin

Subjects: Get full text

Risk of serious bacterial infections in inflammatory rheumatic or bowel disease patients during biological therapies: nationwide Danish cohort study by Emma Cathrine Højberg Platz, Gustav Emil Laugesen, Anne Ahrens Østergaard, Keld-Erik Byg, Inge Petersen, Isik Somuncu Johansen

Subjects: Get full text

Commentary: Anti-TNFα in inflammatory bowel disease: from originators to biosimilars by Yingjie Liu, Keying Wang, Wenjiang Wu

Subjects: Get full text

Role of Tumor Necrosis Factor in Tuberculosis by Fedor D. Kireev, Julia A. Lopatnikova, Alina A. Alshevskaya, Sergey V. Sennikov

Subjects: Get full text

Impact of TNF inhibitors on inflammation-associated cognitive dysfunction in patients with rheumatoid arthritis: a prospective analysis by Natalia Mena-Vázquez, Natalia Mena-Vázquez, Fernando Ortiz-Márquez, Fernando Ortiz-Márquez, Fernando Ortiz-Márquez, Teresa Ramirez-García, Teresa Ramirez-García, Celia Gillis-Onieva, Pablo Cabezudo-García, Pablo Cabezudo-García, Aimara García-Studer, Aimara García-Studer, Aimara García-Studer, Arkaitz Mucientes, Arkaitz Mucientes, Jose Manuel Lisbona-Montañez, Jose Manuel Lisbona-Montañez, Jose Manuel Lisbona-Montañez, Paula Borregón-Garrido, Paula Borregón-Garrido, Patricia Ruiz-Limón, Patricia Ruiz-Limón, Patricia Ruiz-Limón, Sara Manrique-Arija, Sara Manrique-Arija, Sara Manrique-Arija, Laura Cano-García, Laura Cano-García, Pedro Jesús Serrano-Castro, Pedro Jesús Serrano-Castro, Pedro Jesús Serrano-Castro, Antonio Fernández-Nebro, Antonio Fernández-Nebro, Antonio Fernández-Nebro

Subjects: Get full text

Optimizing development of anti-TNFα biosimilars based on 10 years’ experience by Cecil Nick

Subjects: Get full text

Patent and Regulatory Landscape of Biosimilars in the United States and Europe: Implications for Advancing the Domestic Biosimilar Industry with a Focus on Anti-TNF-α Biopharmaceut... by Tae-Kwon Kim, Tai-Hyun Kang

Subjects: Get full text

A Case of Anti‐TNFα Therapies Induced Lupus Panniculitis Successfully Improved With a JAK Inhibitor (Baricitinib) by Cristina Grechin, Jane Doheny, Keith Pilson, Donough Howard, Muireann Roche

Subjects: “…anti‐TNF‐α therapies…”
Get full text

Infliximab treatment for Cronkhite-Canada syndrome in pregnancy: A case report by Ayano Rosemary Nakamura, Shuji Yamamoto, Yoshitsugu Chigusa, Masaki Mandai, Haruta Mogami

Subjects: “…Anti-TNFα therapy…”
Get full text

Clinical effectiveness and safety of ustekinumab in youth with refractory inflammatory bowel disease: A retrospective cohort study by Abdulhamid Alhadab, Amal Almarhoon, Amena AlAlwan, AbdelHai Hammo

Subjects: “…anti-tnf…”
Get full text

Prevalence and clinical implications of anti-drug antibody formation and serum drug levels among patients with IBD receiving anti-TNF therapy: A cross-sectional study by Ahmed Alghamdi, Mohammed Alahmari, Khulood Aljohani, Aisha Alanazi, Bashaar Al Ibrahim, Mishal Alshowair, Marwa Tawfik, Waleed Alghamdi, Salman Alanazi, Faisal Alzayed, Abdullah S Alghamdi, Abdullah Bawazir, Hussam Alhamidi

Subjects: “…anti-tnf…”
Get full text